(Q45358079)

English

Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan

scientific article published on 22 April 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

1 reference

based on heuristic

inferred from title

Hepatitis B virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

neonatal hemochromatosis

1 reference

based on heuristic

inferred from title

author name string

Fu-Hsiung Su

1

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Chyi-Huey Bai

2

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Fang-Yeh Chu

3

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Yu-Shiang Lin

4

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Chien-Tien Su

5

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Chih-Ching Yeh

6

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

language of work or name

0 references

publication date

22 April 2012

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

4034-4039

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Serological pattern "anti-HBc alone": characterization of 552 individuals and clinical significance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.031

7 January 2021

The underlying mechanisms for the 'anti-HBc alone' serological profile

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.031

7 January 2021

Serological pattern ?anti-HBc alone?: Report on a workshop

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.031

7 January 2021

Hepatitis B vaccination alone is not adequate for the categorizing of adult subjects with isolated anti-HBc

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.031

7 January 2021

The response of isolated anti-HBc positive subjects to recombinant hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.031

7 January 2021

Hepatitis B virus DNA in persons with isolated antibody to hepatitis B core antigen who subsequently received hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.031

7 January 2021

Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.031

7 January 2021

Hepatitis B virus infection in adolescents in a rural township--15 years subsequent to mass hepatitis B vaccination in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.031

7 January 2021

Value of anti-HBc screening of blood donors for prevention of HBV infection: results of a 3-year prospective study in Northwestern Greece

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.031

7 January 2021

Occult hepatitis B virus infection: implications in transfusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.031

7 January 2021

Seroepidemiology of hepatitis B virus infection in children: Ten years of mass vaccination in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.031

7 January 2021

Seroprevalence of hepatitis B virus infection in children in Taipei, 1989: five years after a mass hepatitis B vaccination program

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.031

7 January 2021

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.031

7 January 2021

Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.031

7 January 2021

Decline of hepatitis B carrier rate in vaccinated and unvaccinated subjects: sixteen years after newborn vaccination program in Taiwan.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.031

7 January 2021

Seroprevalence of Hepatitis-B infection amongst Taiwanese university students 18 years following the commencement of a national Hepatitis-B vaccination program

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.031

7 January 2021

Hepatitis B seroprevalence and anamnestic response amongst Taiwanese young adults with full vaccination in infancy, 20 years subsequent to national hepatitis B vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.031

7 January 2021

High frequency of HCV infection in individuals with isolated antibody to hepatitis B core antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.031

7 January 2021

Duration of hepatitis B immunity in low risk children receiving hepatitis B vaccinations from birth

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.031

7 January 2021

Determination of immune memory to hepatitis B vaccination through early booster response in college students.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.031

7 January 2021

The prevalence of "anti-HBc alone" and HBV DNA detection among anti-HBc alone in Korea

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.031

7 January 2021

Can the serological status of anti-HBc alone be considered a sentinel marker for detection of occult HBV infection?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.031

7 January 2021

Isolated Antibody to Hepatitis B Core Antigen in Individuals Infected with HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.031

7 January 2021

Risk factors of isolated antibody against core antigen of hepatitis B virus: association with HIV infection and age but not hepatitis C virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.031

7 January 2021

Isolated antibodies against the core antigen of hepatitis B virus in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.031

7 January 2021

Isolated hepatitis B core antibody is associated with HIV and ongoing but not resolved hepatitis C virus infection in a cohort of US women

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.031

7 January 2021

The role of viral load determination for the management of human immunodeficiency virus, hepatitis B virus and hepatitis C virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.031

7 January 2021

Isolated antibody to hepatitis B core is associated with hepatitis C virus co-infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.031

7 January 2021

Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.031

7 January 2021

Frequency and significance of antibodies against hepatitis B core (anti-HBc) antigen as the only serological marker for hepatitis B infection in Lebanese blood donors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.031

7 January 2021

Isolated antibody to hepatitis B core antigen in human immunodeficiency virus type-1-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.031

7 January 2021

Isolated antibody to hepatitis B core antigen in patients with chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.031

7 January 2021

Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.031

7 January 2021

High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.031

7 January 2021

Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: implications in hepatitis B vaccination programs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.031

7 January 2021

Identifiers

10.1016/J.VACCINE.2012.04.031

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45358079&oldid=2075797943"